Concepta PLC (LON:FRI) had its price objective reduced by stock analysts at FinnCap from GBX 1,332 ($17.20) to GBX 968 ($12.50) in a research report issued to clients and investors on Thursday, StockTargetPrices.com reports. The firm presently has a “corporate” rating on the stock.

FRI has been the topic of a number of other research reports. Liberum Capital reaffirmed a “buy” rating and set a GBX 850 ($10.98) price objective on shares of Concepta PLC in a research note on Monday, August 21st. Numis Securities Ltd raised shares of Concepta PLC to an “add” rating and lifted their price target for the company from GBX 300 ($3.87) to GBX 466 ($6.02) in a research note on Thursday, June 22nd. Finally, Peel Hunt reissued a “buy” rating and issued a GBX 120 ($1.55) price target on shares of Concepta PLC in a research note on Monday, September 4th.

ILLEGAL ACTIVITY NOTICE: This piece was first published by American Banking News and is the property of of American Banking News. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/09/10/concepta-plc-fri-price-target-cut-to-gbx-968-by-analysts-at-finncap.html.

About Concepta PLC

Concepta PLC, formerly Frontier Resources International Plc, is a healthcare company. The Company is involved in the development of products and a platform, which targets the personalized mobile health market with a focus on women’s fertility and unexplained infertility. The Company’s portfolio of products includes MyLotus Meter, Ovulation Test, Pregnancy Test and Fertility App.

Stock Target Prices

Receive News & Ratings for Concepta PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concepta PLC and related companies with MarketBeat.com's FREE daily email newsletter.